MARCHE SPECIFIQUE N°4 MARCHE SPECIFIQUE 2026 : VACCIN ANTIGRIPPAL

Deadline:N/A

Tender information
Nord
Type
Contract award
Procedure
Restricted procedure
Ref. number
MARCHE SPECIFIQUE N°4 MARCHE SPECIFIQUE 2026 : VACCIN ANTIGRIPPAL
Contract type
Framework agreement
Duration
44 months
MARCHE SPECIFIQUE N°4 MARCHE SPECIFIQUE 2026 : VACCIN ANTIGRIPPAL La présente consultation a pour objet la fourniture de médicaments pour le compte des établissements adhérents au GCS Pharma Hauts de France. Les caractéristiques techniques des fournitures devront répondre aux prescriptions définies par la présente lettre de consultation. comporte un seul lot.

VACCIN ANTIGRIPPAL

Marché spécifique passé dans le cadre du SAD-Médicaments

Buyer
Centre Hospitalier de Valenciennes
buyer-email@mail.com
organization number
Contract award
tenderer iconSANOFI WINTHROP INDUSTRIEtenderer status icon trophyAwarded

Documents

Document name
Upload date
File size
First document.pdf
1 Jan 1970, 00:001 Bytes
Second document.pdf
1 Jan 1970, 00:001 Bytes
Contract awarded
Important dates
26 Jun - Publication date
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?

Mercell Logo

Feel free to reach out!

Mercell is the leading European provider of e-tendering and procurement systems, and information between buyers and suppliers in the professional market.

We appreciate your input.

© Mercell Group 2026

Terms & Conditions and Privacy Notice

Mercell Group

  • Email: post@mercell.com
  • Phone: +47 21 01 88 00
  • Address: Askekroken 11, 0277 Oslo, Norway

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.